News for Global Blood Therapeutics, Inc. (0IVZ.L)

Pfizer Inc. Chief Executive Officer Albert Bourla said he’ll do “whatever it takes” to keep profits growing, including further cost cuts, as he seeks to fend off allegations of mismanagement from activist investor Starboard Value LP.

Pfizer's (PFE) stock saw an uptick after reports emerged that activist investor Starboard Value has invested $1 billion in the pharmaceutical giant. This develo

SkyQuest projects that the global melatonin market will attain a value of USD 1032.54 million by 2030, with a CAGR of 11% during the forecast period...

The global sickle cell disease treatment market size is anticipated to grow from USD 2 billion to USD 12.38 billion in 10 years. The market will experience...

Chronicling Dr. Ted Love's CEO journey in biotech and the sale of his sickle cell company Global Blood Therapeutics which Pfizer acquired in August 2022 for $5.4 billion

Prominence of Personalized Medicine Approaches as a Notable Trend in the Hemoglobinopathy Market...

The global sickle cell disease treatment market is growing at a CAGR of 19.1% from 2022 to 2030....

The global malaria and sickle cell disease treatment market is growing at a CAGR of 26.5% from 2022 to 2030....

As per the report by Fortune Business Insights, the global Sickle Cell Disease Treatment Market size is projected to reach USD 9.84 billion in 2030, at a...

As per the report by Fortune Business Insights, the global Sickle Cell Disease Treatment Market size is projected to reach USD 8.75 billion in 2029, at a...

Pharma companies have yet to provide investors with convincing post-pandemic strategies. Read more.

/PRNewswire/ -- DelveInsight's 'Sickle Cell Disease Competitive Landscape – 2023' report provides comprehensive global coverage of available, marketed, and...

/PRNewswire/ -- DelveInsight's Sickle Cell Disease Market Insights report includes a comprehensive understanding of current treatment practices, sickle cell...

GuruFocus Article or News written by insider and the topic is about:

GuruFocus Article or News written by insider and the topic is about:

I tried to cross-tally the list of funds and companies banned by the Texas Comptroller with the publicly available holdings of Texan state pension funds. I found little overlap. I wonder whether the banned list was even meant to bite.

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

--Mit den Erlösen wird die Pipeline des Unternehmens an Zytokin-Immuntherapien der nächsten Generation vorangetrieben----Laura Shawver, Christine Siu...